BPA for sodium oxybate
Ended Awarded Last action
- Contract number
- 36E79724A0001
- Awardee
-
Amneal Pharmaceuticals Of New York, LLC UEI LVEBAQTPN615
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $2,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company. The $2,500,000 BPA is for the supply of the pharmaceutical drug sodium oxybate and does not utilize any set-asides. Amneal Pharmaceuticals has been awarded several other federal contracts and IDVs, primarily for the provision of specialized pharmaceutical products and services, including a $1,710,320 Federal Supply Schedule contract with the Department of Veterans Affairs (VA) and a $3,820,762 Other Transaction Agreement with the Department of the Army. Through this BPA and related task orders, the federal government aims to procure sodium oxybate, a medication used to treat conditions such as narcolepsy, over the period of performance from October 2023 through December 2025.
Amneal Pharmaceuticals' experience as a key supplier of pharmaceutical products to various federal agencies, including the VA and Department of Health and Human Services, along with its established capabilities in pharmaceutical manufacturing and medical product development, position the company well to fulfill the requirements of this BPA. The use of this IDV contract vehicle allows federal agencies to efficiently procure Amneal's specialized pharmaceutical offerings through streamlined task order processes over the life of the agreement.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0001?
36E79724A0001 was awarded to Amneal Pharmaceuticals Of New York, LLC by National Acquisition Center (Headquarters) on October 18, 2023.
How much is contract 36E79724A0001 worth?
36E79724A0001's own ceiling is $2,500,000.
Who can order from contract 36E79724A0001?
36E79724A0001 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0001 under another contract?
Yes. 36E79724A0001 is a blanket purchase agreement under 36F79722D0161, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79724A0001 competed?
The extent of competition for 36E79724A0001 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV